Humacyte aims to transform medicine with off-the-shelf, universally implantable, bioengineered human tissue available at commercial scale. Transaction values Humacyte at a pre-money valuation of $800 million with existing Humacyte shareholders rolling over 100% of their equity into equity of the...
Humacyte, Inc., a leading innovator in regenerative medicine and biotechnology, announced that President and CEO Laura Niklason, M.D., Ph.D. will present virtually at the ICR Conference on January 14 at 12:15 p.m. EST. Dr. Niklason will present an overview of Humacyte’s groundbreaking regenerative...
DURHAM, N.C., Jan. 11, 2021 /PRNewswire/ -- Humacyte, Inc., a leading innovator in regenerative medicine and biotechnology, announced that Founder and CEO Laura Niklason, M.D., Ph.D. will present virtually at the 39 th annual J.P. Morgan Healthcare Conference on January 11 at 8:05 a.m. EST. Dr....
DURHAM, N.C., Dec. 9, 2020 /PRNewswire/ -- Humacyte President and CEO Laura Niklason, M.D., Ph.D. will speak at the renowned Milken Institute Future of Health Summit on Wednesday, December 9 at 1:30 p.m. EST. Laura E. Niklason, MD Humacyte, Inc In a session entitled Bringing It All Together:...
Jeffrey Lawson MD, PhD Appointed Chief Surgical Officer and Vice Chairman, to Enhance Product Positioning and Clinical Adoption Business Wire DURHAM, N.C. -- November 20, 2020 Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Laura Niklason MD, PhD has been...
DURHAM, N.C., Oct. 9, 2020 /PRNewswire/ -- A new manuscript published in the highly cited scientific journal Science (also known as Science Magazine ) reveals great strides in the field of regenerative medicine and vascular tissue engineering. Humacyte, Inc....
Honor Recognizes Humacyte’s Progress in Accelerating the Manufacturing Platform and Process for Producing Vascular Conduits for Hemodialysis and Vascular Trauma Business Wire DURHAM, N.C. -- April 8, 2019 Humacyte, an innovator in biotechnology and regenerative medicine, received the Medical...
RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- Humacyte , an innovator in biotechnology and regenerative medicine, announced publication in the medical journal Science Translational Medicine, of pivotal scientific work demonstrating Humacyte’s human acellular vessels (HAVs) repopulate with the...
RESEARCH TRIANGLE PARK, N.C. – January 7, 2019. Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Jeffrey Lawson, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 37th Annual J.P....
